MARKET

CRVO

CRVO

CervoMed
NASDAQ
4.140
+0.140
+3.50%
After Hours: 4.140 0 0.00% 16:04 04/02 EDT
OPEN
3.930
PREV CLOSE
4.000
HIGH
4.410
LOW
3.910
VOLUME
72.25K
TURNOVER
--
52 WEEK HIGH
14.00
52 WEEK LOW
3.510
MARKET CAP
38.33M
P/E (TTM)
-1.3881
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CRVO last week (0323-0327)?
Weekly Report · 5d ago
CervoMed Posts Investor Presentation Under Regulation FD Disclosure
TipRanks · 03/23 20:38
Cervomed Inc. Publishes Presentation Factsheet
Reuters · 03/23 20:08
Weekly Report: what happened at CRVO last week (0316-0320)?
Weekly Report · 03/23 09:50
CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results
TipRanks · 03/19 20:59
CervoMed Price Target Maintained With a $31.00/Share by D. Boral Capital
Dow Jones · 03/19 18:42
CervoMed Is Maintained at Buy by D. Boral Capital
Dow Jones · 03/19 18:42
BUZZ-CervoMed rises as experimental drug shows benefit in early-stage dementia patients
Reuters · 03/19 12:45
More
About CRVO
CervoMed Inc. is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in Lewy bodies (DLB) and certain other neurological disorders. It focuses on reducing the impact of inflammation in the brain, or neuroinflammation, which is a key factor in the manifestation of degenerative diseases of the brain, including DLB. Neflamapimod is being evaluated in the Company's ongoing RewinD-LB Trial, a Phase 2b trial in patients with DLB.

Webull offers CervoMed Inc stock information, including NASDAQ: CRVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRVO stock methods without spending real money on the virtual paper trading platform.